SCHEMBL8779255

SCHEMBL8779255

COC(=O)c1cc(C(=O)OC)c(Cl)c(-c2ccccc2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A3 Q01959 3/20 0.51
SLC6A4 P31645 2/20 0.51
EGFR P00533 1/20 0.51
ACLY P53396 3/20 0.50
PTGS2 P35354 1/20 0.49
TSHR P16473 1/20 0.49
GABRA1 P14867 2/20 0.48
GABRG2 P18507 2/20 0.48
GABRB3 P28472 2/20 0.48
GABRA3 P34903 2/20 0.48
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
MAPT P10636 3/20 0.47
KDM4E B2RXH2 2/20 0.47
LMNA P02545 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
MAPK14 Q16539 1/20 0.46
PDK2 Q15119 2/20 0.46
ALDH1A1 P00352 2/20 0.44
GAA P10253 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10058712 0.80 EGFR (0.63) SLC6A3SLC6A4EGFRPTGS2TSHR
SCHEMBL818748 0.80 PTGS2 (0.59) SLC6A3SLC6A4EGFRPTGS2TSHR
SCHEMBL29109366 0.80 SLC6A3 (0.64) SLC6A3SLC6A4TSHRGABRA1GABRG2
SCHEMBL5988425 0.79 EGFR (0.62) EGFRACLYPTGS2TSHRGABRA1
SCHEMBL28979522 0.78 PTGS2 (0.55) EGFRACLYPTGS2TSHRGABRA1
SCHEMBL30277104 0.78 PDK2 (0.48) SLC6A3SLC6A4EGFRACLYPTGS2
SCHEMBL6735790 0.78 EGFR (0.56) EGFRACLYPTGS2TSHRGABRA1
SCHEMBL12121707 0.77 GABRA1 (0.62) SLC6A3SLC6A4EGFRTSHRGABRA1
SCHEMBL6255108 0.76 SLC6A3 (0.55) SLC6A3SLC6A4EGFRTSHRGABRA1
SCHEMBL27878777 0.76 TSHR (0.68) EGFRTSHRGABRG2GABRB3GABRA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0774458-A1 Substituted benzodicarboxylic acid diguanidines, process for their preparation, and their use as medicament or diagnostic agent HOECHST AKTIENGESELLSCHAFT (DE) 1997-05-21 EP disclosed